Gm. Halliday et al., Clinical and neuropathological abnormalities in baboons treated with HPTP,the tetrahydropyridine analog of haloperidol, EXP NEUROL, 158(1), 1999, pp. 155-163
Tardive dyskinesia (TD) is relatively common among psychiatric patients on
maintenance therapy with typical neuroleptics and persists in more than 20%
even after withdrawal of the medication. Such persistence suggests an unde
rlying pathology due to neurotoxicity. We present evidence for such a neuro
toxic mechanism in a baboon model of TD. Four baboons were treated chronica
lly with the dehydration product of haloperidol, 4-(4 chlorophenyl)-1-[4-(4
-fluorophenyl)oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), which is metabol
ized, similarly to haloperidol, to two neurotoxic pyridinium species. The a
nimals developed orofacial dyskinesia which persisted after HPTP was ceased
. Serial sections of the entire brain from the four treated animals and fou
r vehicle-treated controls revealed volume loss in the basal forebrain and
hypothalamus. Histological evaluation demonstrated a reduction in the densi
ty of magnocellular neurons in the anterior region of the nucleus basalis o
f Meynert (NbM). We speculate that the loss of these NbM neurons may be ass
ociated with the persistent orofacial dyskinesia observed in the HPTP-treat
ed animals. These findings may contribute to a better understanding of neur
oleptic-induced TD. (C) 1999 Academic Press.